Reconnecting

The current page stays visible while onset.to reconnects in the background.

Psilocybin: Effects, Clinical Research, Safety, Cultural History and Legal Status in the United Kingdom

Open original

Psilocybin, a compound found in magic mushrooms, produces psychedelic effects lasting around four to six hours after conversion to psilocin. Clinical studies have investigated its potential for depression, end-of-life anxiety and addiction, though research remains ongoing and evidence for microdosing is limited. Effects can include altered perception and intense emotions; psychological distress is a principal risk, particularly in unsupported settings or for people with certain mental health histories. Mushroom potency varies, and interactions with medicines such as lithium can be dangerous. Preparation, a safe setting and subsequent integration are presented as harm reduction measures. In the UK, psilocybin remains a Class A, Schedule 1 substance, with access restricted to licensed research and rescheduling under discussion.